Sign in
CompletedNo phase

Real-World Study on the Burden of Hidradenitis Suppurativa

Key facts

Who runs it
PeriPharm
Where
Canada1 site in 1 countryChoose a country to see its sites
Trial code
Status
Completed
People taking part
100 people enrolled
Started
20 Feb 2026
Ended
1 Oct 2026
Type of study
Observational
Treatments tested
  • No Intervention: Observational Cohort
Record updated
8 October 2026

Who can take part

Age
18 years and older
Sex
Women and men
Healthy volunteers
Cannot take part

The registry criteria, word for word

Show all 5 criteriaShow less

Who can take part

  • Patient diagnosed with HS
  • Aged ≥18 years
  • Able to read and understand French or English
  • Willing and able to provide written informed consent

Who cannot take part

  • Participation in an interventional study for HS

This trial has no sites in United States.

It has sites in one country. Choose a country to see its sites.

About the trial

What the trial wants to find out

Despite the significant impact of HS on patients' quality of life (QoL) and daily functioning, there remains limited real-world evidence describing the burden of this condition in Canada. HS is an under-recognized and often misdiagnosed condition, with a substantial psychological and physical burden on patients. Understanding the real-world experiences of individuals living with HS in Canada can help identify unmet needs and inform patient-centered care approaches.

The group in the trial

  • Patient with HS

    Patient diagnosed with HS

    Treatment: No Intervention: Observational Cohort

Data and sources

Registry record
Listed on ClinicalTrials.gov.
Record updated
8 October 2026